Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.
Piotr EderBram VerstockEmma CulverGabriele DragoniLea Isabell KredelJoanna WypychAna Garcia Garcia de ParedesMagdalena KaniewskaHaim LeibovitzhTriana LobatonMarie TruyensGrzegorz OraczDavide Giuseppe RibaldoneTeresa StarzyńskaAbdenor BadaouiJean-Francois RahierCristina BezzioPeter BossuytKatherine FalloonDaniela PuglieseCatherine Frakes VozzoTine JessLone LarsenSoren OlensenPartha PalMaría ChaparroDikla DrorPierre EllulIga GromnyMaria JaniakKatarzyna MaciejewskaNoam PelegAriella Bar-Gil ShitritŁukasz SzwedRenata Talar-WojnarowskaYifat SnirRoni WeisshofEran ZittanIzabela MiechowiczIdan GorenPublished in: Journal of Crohn's & colitis (2023)
In this large international cohort of patients with concomitant AIP-IBD, most patients have type 2 AIP and colonic IBD. AIP course is relatively benign and long-term outcomes are favourable, however, one-quarter develop pancreatic complications. Age, familial history of IBD and CD may predict uncomplicated AIP course.